{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T03:45:00Z","timestamp":1775447100797,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.steroids.2018.12.008","type":"journal-article","created":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T09:07:11Z","timestamp":1546765631000},"page":"62-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Establishment of reference intervals for serum concentrations of androstanediol glucuronide by a newly developed LC-MS\/MS method"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5898-8176","authenticated-orcid":false,"given":"Neus","family":"Fabregat-Cabello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie D.","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tugba","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9tienne","family":"Cavalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline M.","family":"Le Goff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2018.12.008_b0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jsbmb.2006.02.004","article-title":"Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women","volume":"99","author":"Labrie","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2018.12.008_b0010","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0960-0760(91)90032-Z","article-title":"Physiopathology of plasma androstanediol-glucuronide","volume":"39","author":"Vermeulen","year":"1991","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2018.12.008_b0015","first-page":"2565","article-title":"Evaluation and treatment of women with hirsutism","volume":"67","author":"Hunter","year":"2003","journal-title":"Am. Fam. Phys."},{"key":"10.1016\/j.steroids.2018.12.008_b0020","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1210\/jcem-67-5-986","article-title":"Correlation of serum 3\u03b1-androstanediol glucuronide with acne and chest hair density in men","volume":"67","author":"Lookingbill","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2018.12.008_b0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jsbmb.2015.02.009","article-title":"A rapid and sensitive UPLC\u2013MS\/MS method for the simultaneous quantification of serum androsterone glucuronide, etiocholanolone glucuronide, and androstan-3\u03b1, 17\u03b2 diol 17-glucuronide in postmenopausal women","volume":"149","author":"Ke","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2018.12.008_b0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1258\/acb.2010.009230","article-title":"A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin","volume":"47","author":"Dorrian","year":"2010","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.steroids.2018.12.008_b0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0009-8981(81)90047-4","article-title":"Development and application of a simple radioimmunoassay for urinary aldosterone","volume":"116","author":"Al-Dujaili","year":"1981","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.steroids.2018.12.008_b0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0039-128X(92)90105-I","article-title":"A direct radioimmunoassay for 5a-androstane-3a,17b-diol 17-glucuronide","author":"Rao","year":"1992","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2018.12.008_b0045","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1172\/JCI110558","article-title":"3a,17beta-androstanediol glucuronide","volume":"69","author":"Horton","year":"1982","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.steroids.2018.12.008_b0050","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1006\/abio.1997.2340","article-title":"A reference method for the analysis of aldosterone in blood by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry","volume":"252","author":"Fredline","year":"1997","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.steroids.2018.12.008_b0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cca.2013.04.028","article-title":"Measurement of dehydroepiandrosterone sulphate (DHEAS): A comparison of isotope-dilution liquid chromatography tandem mass spectrometry (id-lc-ms\/ms) and seven currently available immunoassays","volume":"424","author":"B\u00fcttler","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.steroids.2018.12.008_b0060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1258\/0004563054255632","article-title":"Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid","volume":"42","author":"Allen","year":"2005","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.steroids.2018.12.008_b0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clinbiochem.2010.06.005","article-title":"Progress in automation of LC-MS in laboratory medicine","volume":"44","author":"Vogeser","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.steroids.2018.12.008_b0070","first-page":"5","article-title":"LC-MS\/MS in the clinical laboratory \u2013 where to from here?","volume":"32","author":"Grebe","year":"2011","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.steroids.2018.12.008_b0075","doi-asserted-by":"crossref","unstructured":"J. Trontelj, Quantification of Glucuronide Metabolites in Biological Matrices by LC-MS\/MS, in: Tandem Mass Spectrometry Applications and Principles, 2012, pp. 531\u2013558.","DOI":"10.5772\/30923"},{"key":"10.1016\/j.steroids.2018.12.008_b0080","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1021\/ac4001749","article-title":"Use of LC-MS\/MS for the open detection of steroid metabolites conjugated with glucuronic acid","volume":"85","author":"Fabregat","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.steroids.2018.12.008_b0085","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jsbmb.2009.12.008","article-title":"Detection of the misuse of steroids in doping control","volume":"121","author":"Parr","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2018.12.008_b0090","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jsbmb.2006.09.034","article-title":"Metabolism of DHEA in postmenopausal women following percutaneous administration","volume":"103","author":"Labrie","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2018.12.008_b0095","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1158\/1055-9965.EPI-06-0792","article-title":"Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry","volume":"16","author":"Hsing","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.steroids.2018.12.008_b0100","unstructured":"D. Wild, The Immunoassay Handbook, third ed., 2005."},{"key":"10.1016\/j.steroids.2018.12.008_b0105","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.clinbiochem.2016.04.009","article-title":"LC\u2013MS\/MS analysis of steroids in the clinical laboratory","volume":"49","author":"Keevil","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.steroids.2018.12.008_b0110","unstructured":"U.S. Department of Health and Human Services. Guidance for Industry: Bioanalytical Method Validation, (2001) 4\u201310."},{"key":"10.1016\/j.steroids.2018.12.008_b0115","series-title":"Exploratory Data Analysis","author":"Tukey","year":"1977"},{"key":"10.1016\/j.steroids.2018.12.008_b0120","series-title":"Doping in Sports","author":"Alfi","year":"2010"},{"key":"10.1016\/j.steroids.2018.12.008_b0125","unstructured":"Mayo Clinic. Test ID: FANGL Androstanediol Glucuronide, (n.d.). https:\/\/www.mayomedicallaboratories.com\/test-catalog\/Clinical+and+Interpretive\/75001 (accessed September 26, 2018)."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X19300017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X19300017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T12:41:25Z","timestamp":1573648885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X19300017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":25,"alternative-id":["S0039128X19300017"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2018.12.008","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of reference intervals for serum concentrations of androstanediol glucuronide by a newly developed LC-MS\/MS method","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2018.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}